Cardiovascular risk in patients with psoriasis-relationship with oxidative stress and dyslipidemia
Abstract
Background: Patients with psoriasis are at an increased risk of cardiovascular disease (CVD). Psoriasis and atherosclerosis share the common soil of inflammation and oxidative stress in their pathogenesis. The current study aimed to examine cardiovascular risk in relation to some non-traditional (i.e., biomarkers of oxidative stress and inflammation) and traditional metabolic parameters in patients with psoriasis.
Methods: A total of 68 (57% men) patients with psoriasis were included. Traditional metabolic parameters, markers of oxidative stress [i.e., oxidation protein products (AOPP), malondialdehyde (MDA), catalase (CAT), and superoxide dismutase (SOD)] and inflammation (C-reactive protein) were measured. The atherosclerotic cardiovascular disease (ASCVD) risk score was used to measure CVD risk. Patients were divided into ASCVD score tertiles.
Results: Patients with a higher ASCVD score had significantly lower high-density lipoprotein cholesterol (HDL-C), higher triglycerides (TG), and higher TG/HDL-C ratio (p for trend p<0.001). Among redox status parameters, only AOPP showed significant increase in parallel with the ASCVD score increase (p=0.011). In univariate binary logistic regression analysis, AOPP [OR, 95% CI=1.027 (1.004-1.051), p=0.021] and TG [OR, 95% CI =7.220 (2.041-25.548), p=0.002] correlated with the ASCVD risk score. In multivariate analysis (backward method) only TG was an independent predictor of ASCVD score [OR, 95%CI =7.220 (2.041-25.548), p=0.002].
Conclusion: The results show the association between ASCVD score and oxidative stress (AOPP) and dyslipidemia (TG), respectively, in patients with psoriasis, but only TG retained its independent association with ASCVD risk score. The measurement of serum TG levels is of great importance in patients with increased ASCVD risk concerning psoriasis.
Copyright (c) 2025 Vesna Karanikolic, Mirjana Bakic, Sanja Gluscevic, Filiz Mercantepe, Aleksandra Klisic
This work is licensed under a Creative Commons Attribution 4.0 International License.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.